List of bibliographic references
Number of relevant bibliographic references: 24.
[0-20] [
0 - 20][
0 - 24][
20-23][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000086 (2020) |
Paolo Verdecchia ; Claudio Cavallini ; Antonio Spanevello ; Fabio Angeli | The pivotal link between ACE2 deficiency and SARS-CoV-2 infection |
| 000096 (2020) |
Michael J. Butler [États-Unis] ; Ruth M. Barrientos [États-Unis] | The impact of nutrition on COVID-19 susceptibility and long-term consequences |
| 000133 (2020) |
Maryam Hannah Daud ; Anis Safura Ramli ; Suraya Abdul-Razak ; Mohamad Rodi Isa ; Fakhrul Hazman Yusoff ; Noorhida Baharudin ; Mohamed Syarif Mohamed-Yassin ; Siti Fatimah Badlishah-Sham ; Azlina Wati Nikmat ; Nursuriati Jamil ; Hapizah Mohd-Nawawi | The EMPOWER-SUSTAIN e-Health Intervention to improve patient activation and self-management behaviours among individuals with Metabolic Syndrome in primary care: study protocol for a pilot randomised controlled trial |
| 000142 (2020) |
Rinkoo Dalan [Singapour] ; Stefan R. Bornstein [Singapour] ; Ali El-Armouche [Allemagne] ; Roman N. Rodionov [Allemagne] ; Alexander Markov [Russie] ; Ben Wielockx [Allemagne] ; Felix Beuschlein [Suisse] ; Bernhard O. Boehm [Singapour] | The ACE-2 in COVID-19: Foe or Friend? |
| 000146 (2020) |
Amerta Ghosh [Inde] ; Ritesh Gupta [Inde] ; Anoop Misra [Inde] | Telemedicine for Diabetes Care in India during COVID19 Pandemic and National Lockdown Period: Guidelines for Physicians |
| 000193 (2020) |
Konstantinos Michalakis [Grèce] ; Ioannis Ilias [Grèce] | SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects |
| 000207 (2020) |
Nathaniel Morin | Response to COVID -19 and Diabetes: Can DPP4 Inhibition Play a Role? – GLP-1 Might Play One Too |
| 000268 (2020) |
Stefan R. Bornstein [Allemagne, Royaume-Uni, Suisse] ; Francesco Rubino [Royaume-Uni] ; Kamlesh Khunti [Royaume-Uni] ; Geltrude Mingrone [Royaume-Uni, Italie] ; David Hopkins [Royaume-Uni] ; Andreas L. Birkenfeld [Royaume-Uni, Allemagne] ; Bernhard Boehm [Singapour] ; Stephanie Amiel [Royaume-Uni] ; Richard Ig Holt [Royaume-Uni] ; Jay S. Skyler [États-Unis] ; J Hans Devries [Pays-Bas, Allemagne] ; Eric Renard [France] ; Robert H. Eckel [États-Unis] ; Paul Zimmet [Australie] ; Kurt George Alberti [Royaume-Uni] ; Josep Vidal [Espagne] ; Bruno Geloneze [Brésil] ; Juliana C. Chan [République populaire de Chine] ; Linong Ji [République populaire de Chine] ; Barbara Ludwig [Allemagne, Suisse] | Practical recommendations for the management of diabetes in patients with COVID-19 |
| 000373 (2020) |
Casey Means | Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy |
| 000391 (2020) |
Akhtar Hussain | Letter to the Editor in Response to article: “Clinical considerations for patients with diabetes in times of COVID-19 epidemic (Gupta et al.) |
| 000467 (2020) |
Rebecca J. Marshall [Australie] ; Pornthida Armart [Australie] ; Katina D. Hulme [Australie] ; Keng Yih Chew [Australie] ; Alexandra C. Brown [Australie] ; Philip M. Hansbro [Australie] ; Conor J. Bloxham [Australie] ; Melanie Flint [Australie] ; Katharina Ronacher [Australie] ; Helle Bielefeldt-Ohmann [Australie] ; Linda A. Gallo [Australie] ; Kirsty R. Short [Australie] | Glycemic Variability in Diabetes Increases the Severity of Influenza. |
| 000484 (2020) |
Ondrej Hrusak ; Tomas Kalina ; Joshua Wolf [États-Unis] ; Adriana Balduzzi [Italie] ; Massimo Provenzi [Italie] ; Carmelo Rizzari ; Susana Rives [Espagne] ; María Del Pozo Carlavilla [Espagne] ; Maria Eli Valerio Alonso [Espagne] ; Nerea Domínguez Pinilla [Espagne] ; Jean-Pierre Bourquin [Suisse] ; Kjeld Schmiegelow [Danemark] ; Andishe Attarbaschi [Autriche] ; Pernilla Grillner [Suède] ; Karin Mellgren [Suède] ; J. Ten Bosch Van Der Werff [Belgique] ; Rob Pieters [Pays-Bas] ; Triantafyllia Brozou ; Arndt Borkhardt ; Gabriele Escherich [Allemagne] ; Melchior Lauten [Allemagne] ; Martin Stanulla [Allemagne] ; Owen Smith [Irlande (pays)] ; Allen Eng Juh Yeoh [Singapour] ; Sarah Elitzur ; Ajay Vora [Royaume-Uni] ; Chi-Kong Li [Hong Kong] ; Hany Ariffin [Malaisie] ; Alexandra Kolenova [Slovaquie] ; Luciano Dallapozza [Australie] ; Roula Farah [Liban] ; Jelena Lazic [Serbie] ; Atsushi Manabe [Japon] ; Jan Styczynski [Pologne] ; Gabor Kovacs [Hongrie] ; Gabor Ottoffy [Hongrie] ; Marisa Felice [Argentine] ; Barbara Buldini [Italie] ; Valentino Conter [Italie] ; Jan Stary ; Martin Schrappe [Allemagne] | Flash Survey on SARS-CoV-2 Infections in Pediatric Patients on anti-Cancer Treatment |
| 000508 (2020) |
Samit Ghosal [Inde] ; Binayak Sinha [Inde] ; Milan Majumder [Inde] ; Anoop Misra [Inde] | Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: A simulation model using multivariate regression analysis |
| 000609 (2020) |
Michael A. Hill [États-Unis] ; Christos Mantzoros [États-Unis] ; James R. Sowers [États-Unis] | Commentary: COVID-19 in patients with diabetes |
| 000610 (2020) |
Carmen V. Villabona | Commentary: COVID-19 and diabetes |
| 000617 (2020) |
Akhtar Hussain | Clinical considerations for patients with diabetes in times of COVID-19 epidemic |
| 000640 (2020) |
Yu Kang [États-Unis] ; Tiffany Chen [États-Unis] ; David Mui [États-Unis] ; Victor Ferrari [États-Unis] ; Dinesh Jagasia [États-Unis] ; Marielle Scherrer-Crosbie [États-Unis] ; Yucheng Chen [République populaire de Chine] ; Yuchi Han [États-Unis] | Cardiovascular manifestations and treatment considerations in covid-19. |
| 000645 (2020) |
Elena Carboni [Italie] ; Anna Rosa Carta [Italie] ; Ezio Carboni [Italie] | Can pioglitazone be potentially useful therapeutically in treating patients with covid-19? |
| 000707 (2020) |
Antonio Ceriello [Italie] ; Anca Pantea Stoian [Roumanie] ; Manfredi Rizzo [États-Unis, Italie] | COVID-19 and diabetes management: What should be considered? |
| 000708 (2020) |
Akhtar Hussain [Norvège, Brésil, Belgique, Inde, Bangladesh] ; Bishwajit Bhowmik [Bangladesh, Norvège] ; Nayla Cristina Do Vale Moreira [Brésil, Norvège] | COVID-19 and Diabetes: Knowledge in Progress |
| 000744 (2020) |
Yaron Ogen | Assessing nitrogen dioxide (NO2) levels as a contributing factor to coronavirus (COVID-19) fatality |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "diabetes"
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i \
-Sk "diabetes" \
| HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= StressCovidV1
|flux= 2020
|étape= Analysis
|type= indexItem
|index= AbsEn.i
|clé= diabetes
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021 |  |
